Target intelligence / Profile preview

Ionophore

Molecular classification
Other (not a single molecule, but a functional class including small molecules and peptides)
01

Overview

Ionophores are a class of natural and synthetic compounds—often lipid-soluble small molecules or peptides—that enable the transport of specific ions across the hydrophobic membrane bilayer of cells. Unlike typical therapeutic targets such as receptors or enzymes, ionophores operate by shuttling ions (including sodium, potassium, calcium, chloride, etc.) across lipid bilayers, either by binding and carrying the ion (mobile carrier ionophores, e.g., valinomycin) or by forming a passage/channel through which ions can flow (channel-forming ionophores, e.g., gramicidin). This activity can disrupt normal ion gradients, altering membrane potential and cellular activity. Some ionophores have clinical or experimental applications as antimicrobial agents, anticancer drugs, or as research tools to probe membrane dynamics and transport. Ionophore-mediated disruption of ion gradients can induce cell death, making them candidates for antimicrobial and anticancer applications, though their non-selective action also predisposes to toxicity. "Ionophore activity" is thus a functional property or effect, not a distinct molecular entity, and is considered an inappropriate or incorrect "target" for structured pharmacological data.

Other names
Ion carrierIon channel-forming agent
02

Mechanism of action

Catalysis of passive or facilitated diffusion of ions across lipid membranes; disrupt ion gradients; act as mobile carriers or form hydrophilic channels depending on structure; induce apoptosis via ion imbalance; alter cellular homeostasis

03

Biological functions

Ion transportDisruption/regulation of ion gradientsModulation of membrane potentialCell signalingInduction of apoptosis (depending on context)
04

Disease associations

Infection (antimicrobial and antiparasitic usage)Cancer (anticancer drug functions)Channelopathies (potential as channel replacement therapy)Other (used as growth promoters in animals)
05

Safety considerations

Cytotoxicity due to ion imbalancenarrow therapeutic indexpotential for non-selective cytotoxicitypotential toxicity in animals at higher concentrationsrisk of disrupting essential physiological ion gradients
06

Interacting drugs

Valinomycin

7 more in the full profile.

Beyond the preview

Go deeper on Ionophore.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ionophore.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call